Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis-Reference-Cited by-同舟云学术

Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis

Published:2013-04-26 Issue:5 Volume:73 Page:921-927
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Gierman L M,Kühnast S,Koudijs A,Pieterman E J,Kloppenburg M,van Osch G J V M,Stojanovic-Susulic V,Huizinga T W J,Princen H M G,Zuurmond A-M

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference43 articles.

1. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study;Dahaghin;Ann Rheum Dis,2007

2. Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome;Katz;Curr Opin Rheumatol,2010

3. Osteoarthritis: another component of metabolic syndrome?;Velasquez;Metab Syndr Relat Disord,2010

4. Metabolic syndrome, or What you will: definitions and epidemiology;Day;Diab Vasc Dis Res,2007

5. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data;Puenpatom;Postgrad Med,2009

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the causal link among statin drugs and the osteoarthritis risk based on Mendelian randomization research;Frontiers in Genetics;2024-09-04

2. Unravelling the ties that bind: The intersection of obesity, osteoarthritis, and inflammatory pathways with emphasis on glucagon‐like peptide‐1 agonists;Clinical Obesity;2024-08-16

3. Targeting RIP3 inhibits osteoarthritis development by restoring anabolic-catabolic balance in the bone-cartilage unit;Medicine Plus;2024-06

4. Efficacy and safety of pentosan polysulfate sodium in people with symptomatic knee osteoarthritis and dyslipidaemia: protocol of the MaRVeL trial;BMJ Open;2024-05

5. Zexieyin formula alleviates atherosclerosis with cognitive impairment: A novel role in the treatment of comorbidities and its underlying mechanisms;Journal of Ethnopharmacology;2024-04